Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts

Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts

<p>A strong positive association has been observed between circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and breast cancer risk in three prospective studies. Confirming this association is important because of the paucity of biomarkers of breast cancer risk in preme...

Descripció completa

Dades bibliogràfiques
Autors principals:	Ge, W, Clendenen, TV, Afanasyeva, Y, Koenig, KL, Agnoli, C, Brinton, LA, Dorgan, JF, Eliassen, AH, Falk, RT, Hallmans, G, Hankinson, SE, Hoffman-Bolton, J, Key, TJ, Krogh, V, Nichols, HB, Sandler, DP, Schoemaker, MJ, Sluss, PM, Sund, M, Swerdlow, AJ, Visvanathan, K, Liu, M, Zeleniuch-Jacquotte, A
Format:	Journal article
Publicat:	Wiley 2018

Ítems similars

Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
per: Tess V. Clendenen, et al.
Publicat: (2019-03-01)

Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts
per: Jung, S, et al.
Publicat: (2017)

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
per: Fortner, RT, et al.
Publicat: (2017)

Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
per: T. V. Clendenen, et al.
Publicat: (2022-04-01)

Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
per: Tess V Clendenen, et al.
Publicat: (2015-01-01)

Temporal reliability of cytokines and growth factors in EDTA plasma
per: Marrangoni Adele M, et al.
Publicat: (2010-11-01)

Free estradiol and breast cancer risk in postmenopausal women: Comparison of measured and calculated values
per: Key, T, et al.
Publicat: (2003)

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
per: Key, T, et al.
Publicat: (2003)

Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
per: Clendenen, T, et al.
Publicat: (2019)

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.
per: Key, T, et al.
Publicat: (2013)

Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women
per: Jung, S, et al.
Publicat: (2017)

The Premenopausal Breast Cancer Collaboration: A pooling project of studies participating in the National Cancer Institute Cohort Consortium
per: Nichols, HB, et al.
Publicat: (2017)

Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women’s Health Study for breast cancer
per: Myeonggyun Lee, et al.
Publicat: (2023-05-01)

Persistent Mullerian Duct Syndrome with Malignant Conversion of Mullerian Remnant
per: Abhilasha Jain, et al.
Publicat: (2022-05-01)

Physiological role and diagnostic value of anti-Mullerian hormone in pediatrics
per: T.V. Sorokman, et al.
Publicat: (2022-10-01)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
per: Richard L. Cate
Publicat: (2022-06-01)

Adult weight change and premenopausal breast cancer risk: a prospective pooled analysis of data from 628,463 women
per: Schoemaker, MJ, et al.
Publicat: (2020)

Diagnostic value of anti-Mullerian hormone in adolescent girls with polycystic ovary syndrome
per: T.V. Sorokman, et al.
Publicat: (2022-05-01)

Familial müllerian agenesis
per: F Tiker, et al.
Publicat: (2000-10-01)

Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors
per: Mitra Heidarpour, et al.
Publicat: (2014-01-01)

Application areas of modern automated methods of anti-Müllerian hormone evaluation
per: O.A. Burka, et al.
Publicat: (2021-07-01)

Persistent mullerian duct syndrome
per: Renu Divya, et al.
Publicat: (2010-01-01)

Persistent mullerian duct syndrome
per: Divya Renu, et al.
Publicat: (2010-01-01)

Frequency of Mullerian Duct Abnormalities
per: Humaira Rani
Publicat: (2009-06-01)

Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case–control study in the Northern Sweden Maternity Cohort
per: Renée T. Fortner, et al.
Publicat: (2017-07-01)

Association of body mass index and age with subsequent breast cancer risk in premenopausal women
per: Premenopausal Breast Cancer Collaborative Group, et al.
Publicat: (2018)

Association of body mass index and age with subsequent breast cancer risk in premenopausal women
per: Schoemaker, MJ, et al.
Publicat: (2018)

The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis
per: Shin Young Kim, et al.
Publicat: (2018-01-01)

Müllerian Agenesis Masquerading as Secondary Amenorrhea
per: Gloria Tavera, et al.
Publicat: (2018-01-01)

Mullerian anomalies: revisiting imaging and classification
per: Rashmi Dixit, et al.
Publicat: (2025-02-01)

Extragenital Müllerian Adenosarcoma in the Pouch of Douglas
per: Ateş Karateke, et al.
Publicat: (2014-03-01)

Mullerian Adenosarcoma of the Uterus with Sarcomatous Overgrowth
per: Reecha Singh, et al.
Publicat: (2010-01-01)

Benign Retroperitoneal Cyst of Mullerian Type
per: Jay Yohendran, et al.
Publicat: (2004-10-01)

Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies
per: Nichols, HB, et al.
Publicat: (2018)

Müllerian Remnant Cyst as a Cause of Acute Abdomen in a Female Patient with Müllerian Agenesis: Radiologic and Pathologic Findings
per: Mujtaba Mohammed, et al.
Publicat: (2016-01-01)

Müllerian Cyst of the Vagina Masquerading as a Cystocele
per: Emrah Töz, et al.
Publicat: (2015-01-01)

Müllerian anomalies and endometriosis: associations and phenotypic variations
per: Surya Bhamidipaty-Pelosi, et al.
Publicat: (2024-12-01)

Persistent Müllerian Duct Syndrome: Understanding the Challenges
per: Irene Chua, et al.
Publicat: (2022-01-01)

Anti-Mullerian Hormone: Usefulness in Clinical Practice
per: Kai J. Buhling, et al.
Publicat: (2013-01-01)

Anti-Mullerian hormone in systemic lupus erythematosus
per: Z. S. Alekberova, et al.
Publicat: (2021-02-01)